RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+36.95%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$777M
AUM Growth
+$777M
(+25%)
Cap. Flow
-$2.93M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
67.53%
Holding
55
New
12
Increased
4
Reduced
8
Closed
7
Top Buys
| 1 |
RGLS
Regulus Therapeutics
RGLS
|
$76.1M |
| 2 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$25.4M |
| 3 |
TG Therapeutics
TGTX
|
$20.4M |
| 4 |
FWP
Forward Pharma A/S American Depositary Shares
FWP
|
$20.2M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$17.8M |
Top Sells
| 1 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$64.2M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$40.3M |
| 3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$34.8M |
| 4 |
BLUE
bluebird bio
BLUE
|
$20.4M |
| 5 |
Dynavax Technologies
DVAX
|
$17.4M |
Sector Composition
| 1 | Healthcare | 77.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioCryst Pharmaceuticals
BCRX
$1.74B
| $85.7M | 9.21% | 7,050,356 -18,803 | -0.3% | -$229K |
|
|
ACHN
2
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $82.1M | 8.82% | 6,700,000 | – | – |
|
|
RGLS
3
DELISTED
Regulus Therapeutics
RGLS
| $76.1M | 8.18% | +4,742,911 | New | +$76.1M |
|
|
DYAX
4
DELISTED
DYAX CORPORATION
DYAX
| $69.5M | 7.47% | 4,945,697 -2,863,442 | -37% | -$40.3M |
|
|
5
TG Therapeutics
TGTX
$4.65B
| $53.1M | 5.7% | 3,350,449 +1,284,878 | +62% | +$20.4M |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| $46.4M | 4.99% | 506,122 -222,690 | -31% | -$20.4M |
|
|
DRNA
7
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $40M | 4.3% | 2,428,571 | – | – |
|
|
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $25.4M | 2.73% | +1,555,355 | New | +$25.4M |
|
|
ZSPH
9
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $23.5M | 2.52% | 564,483 | – | – |
|
10
Larimar Therapeutics
LRMR
$310M
| $22.6M | 2.43% | 732,960 | – | – |
|
11
Xencor
XNCR
$580M
| $22.4M | 2.41% | 1,399,423 +150,500 | +12% | +$2.41M |
|
|
FWP
12
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $20.2M | 2.17% | +970,600 | New | +$20.2M |
|
13
Novavax
NVAX
$1.21B
| $19.2M | 2.07% | 3,241,083 -1,826,000 | -36% | -$10.8M |
|
14
Sangamo Therapeutics
SGMO
$157M
| $18.6M | 1.99% | 1,220,209 | – | – |
|
|
TRVN
15
DELISTED
Trevena, Inc.
TRVN
| $17.8M | 1.91% | +2,974,647 | New | +$17.8M |
|
|
JUNO
16
DELISTED
Juno Therapeutics, Inc.
JUNO
| $14.6M | 1.57% | +280,000 | New | +$14.6M |
|
17
TherapeuticsMD
TXMD
$12.8M
| $14.3M | 1.54% | 3,211,132 -243,200 | -7% | -$1.08M |
|
|
ISEE
18
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $13.9M | 1.5% | 310,554 -278,387 | -47% | -$12.5M |
|
19
Protara Therapeutics
TARA
$120M
| $13M | 1.4% | +1,250,000 | New | +$13M |
|
20
Tenax Therapeutics
TENX
$27.3M
| $10.3M | 1.1% | 2,670,300 +333,925 | +14% | +$1.28M |
|
|
BLCM
21
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $9.34M | 1% | +1,026,402 | New | +$9.34M |
|
22
Aurinia Pharmaceuticals
AUPH
$1.58B
| $9.01M | 0.97% | +2,474,076 | New | +$9.01M |
|
23
SCYNEXIS
SCYX
$34.9M
| $8.38M | 0.9% | 840,000 | – | – |
|
24
Rockwell Medical
RMTI
$58.9M
| $7.26M | 0.78% | +706,252 | New | +$7.26M |
|
25
Akebia Therapeutics
AKBA
$833M
| $6.95M | 0.75% | 597,363 | – | – |
|